Generated by AI
Sight Sciences, Inc. is an ophthalmic medical device company focused on developing and commercializing interventional technologies for glaucoma and dry eye disease. Its current product portfolio includes the OMNI Surgical System family for minimally invasive glaucoma procedures, the SION Surgical Instrument for trabecular meshwork excision, and the TearCare System for treating evaporative dry eye associated with meibomian gland dysfunction. The company serves eyecare providers, including ophthalmologists and optometrists, by offering tools designed to address key causes of intraocular pressure buildup and tear-film dysfunction. Sight Sciences operates through its Surgical Glaucoma and Dry Eye segments, positioning its products across procedural eyecare settings where device-based treatment options are used to support patient care. Headquartered in Menlo Park, California, Sight Sciences plays a focused role in the medical technology market by supplying specialized devices for prevalent eye conditions.
Website4040 Campbell Avenue
Menlo Park, CA, 94025
United States
The latest articles about SGHT.
Sight Sciences Inc (SGHT) posts record $24.9 million in Q3 revenue, lifts full-year 2026 guidance to $92--$93 million, and scales its IDE business with 222 ordering accounts.
While the top- and bottom-line numbers for Sight Sciences (SGHT) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Summary of Mar 30's posts. Generated by AI.
No summary yet.
Summary of Oct 18's posts. Generated by AI.
Sight Sciences (SGHT) delivered earnings and revenue surprises of 0.00% and +6.46%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
No summary yet.
Summary of Oct 17's posts. Generated by AI.
Investors talking about SGHT also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.